Fennec Pharmaceuticals
FENC
FENC
31 hedge funds and large institutions have $65.7M invested in Fennec Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8.38% more ownership
Funds ownership: 42.54% → 50.92% (+8.4%)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Holders
31
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$225K | |
| 2 | +$186K | |
| 3 | +$154K | |
| 4 |
Goldman Sachs
New York
|
+$92K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$82.9K |
Top Sellers
| 1 | -$455K | |
| 2 | -$149K | |
| 3 | -$139K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$135K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$19.5K |